WY
37
-2
NI
60
-2
SWN
52
-3
HPQ
75
5
HRB
76
-3
BSX
71
-2
MAC
72
2
MTB
59
3
ADI
67
4
FOXA
48
3
FCX
63
-4
CME
58
6
DHR
52
2
LRCX
61
2
AIZ
73
-2
TEL
82
2
ACN
45
2
NRG
79
4
HES
72
-2
NWSA
78
-4
WY
37
-2
NI
60
-2
SWN
52
-3
HPQ
75
5
HRB
76
-3
BSX
71
-2
MAC
72
2
MTB
59
3
ADI
67
4
FOXA
48
3
FCX
63
-4
CME
58
6
DHR
52
2
LRCX
61
2
AIZ
73
-2
TEL
82
2
ACN
45
2
NRG
79
4
HES
72
-2
NWSA
78
-4
Financhill
Back

Molecular Partners AG 10K Form

Sell
34

MOLN
Molecular Partners AG

Last Price:
3.55
Seasonality Move:
-16.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MOLN News And Ratings

See the #1 stock for the next 7 days that we like better than MOLN

MOLN Financial Statistics

Sales & Book Value

Annual Sales: $7.84M
Cash Flow: $-17.34M
Price / Cash Flow: 0
Annual Sales: $6.39
Price / Book: 0.59

Profitability

EPS (TTM): -2.10440
Net Income (TTM): $-69.02M
Gross Margin: --
Return on Equity: -30%
Return on Assets: -26.93%

Molecular Partners AG Earnings Forecast

Key Molecular Partners AG Financial Ratios

  • The Research & Development expenses have been 693.15% of Revenue.
  • The Interest Expense is -0.05% of Operating Income.
  • The Net Earning history of MOLN is -880.71% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Molecular Partners AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MOLN
Website: molecularpartners.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 13.35
Quick Ratio: 13.18

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MOLN Technical Analysis vs Fundamental Analysis

Sell
34
Molecular Partners AG (MOLN) is a Sell

Is Molecular Partners AG a Buy or a Sell?